Sign in

CIK 0001645113

  • Large accelerated filer

NovoCure Ltd

Sign in to watch
Ticker
NVCR
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
FY end
Dec 31
Entity type
Operating
Phone
+44 1534756700
Business address
NO. 4 THE FORUM, GRENVILLE STREET, ST. HELIER, Jersey
  1. 4 Exercise or conversion Chief Financial Officer acquired 17,968 shares (option exercise)
  2. 4 Open-market sale Chief Financial Officer sold 883 shares at $21.82 ($19,265)
  3. 4 Open-market sale Chief Operating Officer sold 294 shares at $21.82 ($6,414)
  4. 4 Open-market sale Chief Growth Officer sold 273 shares at $21.82 ($5,956)
  5. 4 Open-market sale Chief Financial Officer sold 1,144 shares at $30.25 ($34,607)
  6. 4 Grant or award Chief Innovation Officer acquired 305 shares (grant or award)
  7. 4 Grant or award Chief Operating Officer acquired 366 shares (grant or award)
  8. 4 Grant or award Chief Growth Officer acquired 367 shares (grant or award)
  9. 4 Grant or award Chief Human Resources Officer acquired 357 shares (grant or award)
  10. 4 Grant or award General Counsel acquired 288 shares (grant or award)
  11. 4 Grant or award Chief Financial Officer acquired 367 shares (grant or award)
  12. 4 Grant or award Chief Executive Officer acquired 367 shares (grant or award)
  13. 4 Grant or award Director acquired 3,853 shares (grant or award)
  14. 4 Grant or award Director acquired 3,853 shares (grant or award)
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Grant or award Director acquired 3,853 shares (grant or award)
  18. 4 Derivatives Options or other derivatives
  19. 4/A Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 8 of 39 · 780 filings